These approaches should be implemented proactively, particularly during treatment initiation and dose escalation
The Precision Peptide Genetic Test reveals predispositions in key peptide pathway variants (GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may influence how your body responds to GLP-1 activation
Patients with indicators of high-risk or established ASCVD, chronic kidney disease, or heart failure According to the ADA, when considering an agent for add-on to metformin background therapy, the first recommended consideration is whether or not the patient has indicators of high-risk or established ASCVD, chronic kidney disease (CKD), or heart failure ( Figure 2 )
Training volume may need reduction during significant caloric deficits
In the Central Nervous System GH and IGF-1 both contribute to neural development, nerve myelination, amyloid clearance so important in the development of Alzheimers disease and anti-inflammatory mechanisms within the central nervous system